Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

D. B. Blossom, R. H. Beigi, J. J. Farrell, W. Mackay, B. Qadadri, Darron Brown, S. Rwambuya, C. J. Walker, F. S. Kambugu, F. W. Abdul-Karim, C. C. Whalen, R. A. Salata

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross-sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2% (49/106). HIV prevalence was 34.9% (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy-three percent (27/37) of HIV-positive women versus 16% (10/63) of HIV-negative women had abnormal Pap smears (P < 0.0001). Among HIV-positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population.

Original languageEnglish
Pages (from-to)758-765
Number of pages8
JournalJournal of Medical Virology
Volume79
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Virus Diseases
Genotype
HIV
Papanicolaou Test
Uterine Cervical Neoplasms
Uganda
Papillomavirus Infections
Sexually Transmitted Diseases
Papillomavirus Vaccines
Serology
Developing Countries
Cross-Sectional Studies
Polymerase Chain Reaction

Keywords

  • Cervical cancer
  • Cervical cytologic abnormalities
  • HPV genotypes
  • Human immunodeficiency virus (HIV)
  • Human papillomavirus (HPV)

ASJC Scopus subject areas

  • Virology

Cite this

Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. / Blossom, D. B.; Beigi, R. H.; Farrell, J. J.; Mackay, W.; Qadadri, B.; Brown, Darron; Rwambuya, S.; Walker, C. J.; Kambugu, F. S.; Abdul-Karim, F. W.; Whalen, C. C.; Salata, R. A.

In: Journal of Medical Virology, Vol. 79, No. 6, 06.2007, p. 758-765.

Research output: Contribution to journalArticle

Blossom, DB, Beigi, RH, Farrell, JJ, Mackay, W, Qadadri, B, Brown, D, Rwambuya, S, Walker, CJ, Kambugu, FS, Abdul-Karim, FW, Whalen, CC & Salata, RA 2007, 'Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women', Journal of Medical Virology, vol. 79, no. 6, pp. 758-765. https://doi.org/10.1002/jmv.20817
Blossom, D. B. ; Beigi, R. H. ; Farrell, J. J. ; Mackay, W. ; Qadadri, B. ; Brown, Darron ; Rwambuya, S. ; Walker, C. J. ; Kambugu, F. S. ; Abdul-Karim, F. W. ; Whalen, C. C. ; Salata, R. A. / Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. In: Journal of Medical Virology. 2007 ; Vol. 79, No. 6. pp. 758-765.
@article{de80943b3deb4e66a0f14931b3a2a0e7,
title = "Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women",
abstract = "Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross-sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2{\%} (49/106). HIV prevalence was 34.9{\%} (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy-three percent (27/37) of HIV-positive women versus 16{\%} (10/63) of HIV-negative women had abnormal Pap smears (P < 0.0001). Among HIV-positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population.",
keywords = "Cervical cancer, Cervical cytologic abnormalities, HPV genotypes, Human immunodeficiency virus (HIV), Human papillomavirus (HPV)",
author = "Blossom, {D. B.} and Beigi, {R. H.} and Farrell, {J. J.} and W. Mackay and B. Qadadri and Darron Brown and S. Rwambuya and Walker, {C. J.} and Kambugu, {F. S.} and Abdul-Karim, {F. W.} and Whalen, {C. C.} and Salata, {R. A.}",
year = "2007",
month = "6",
doi = "10.1002/jmv.20817",
language = "English",
volume = "79",
pages = "758--765",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

AU - Blossom, D. B.

AU - Beigi, R. H.

AU - Farrell, J. J.

AU - Mackay, W.

AU - Qadadri, B.

AU - Brown, Darron

AU - Rwambuya, S.

AU - Walker, C. J.

AU - Kambugu, F. S.

AU - Abdul-Karim, F. W.

AU - Whalen, C. C.

AU - Salata, R. A.

PY - 2007/6

Y1 - 2007/6

N2 - Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross-sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2% (49/106). HIV prevalence was 34.9% (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy-three percent (27/37) of HIV-positive women versus 16% (10/63) of HIV-negative women had abnormal Pap smears (P < 0.0001). Among HIV-positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population.

AB - Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross-sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2% (49/106). HIV prevalence was 34.9% (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy-three percent (27/37) of HIV-positive women versus 16% (10/63) of HIV-negative women had abnormal Pap smears (P < 0.0001). Among HIV-positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population.

KW - Cervical cancer

KW - Cervical cytologic abnormalities

KW - HPV genotypes

KW - Human immunodeficiency virus (HIV)

KW - Human papillomavirus (HPV)

UR - http://www.scopus.com/inward/record.url?scp=34248209760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248209760&partnerID=8YFLogxK

U2 - 10.1002/jmv.20817

DO - 10.1002/jmv.20817

M3 - Article

C2 - 17457908

AN - SCOPUS:34248209760

VL - 79

SP - 758

EP - 765

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 6

ER -